[1] Yan HH, Ding YD, Guo WB. Epidemiological, radiographical, and laboratorial characteristics of Chinese asymptomatic cases with COVID-19: a systematic review and meta-analysis. Front Public Health 2022;10:808471. http://dx.doi.org/10.3389/fpubh.2022.808471CrossRef
[2] Zhang CB, Wang HZ, Wen ZL, Gu MJ, Liu LY, Li XQ. Asymptomatic transmissibility calls for implementing a Zero-COVID strategy to end the current global crisis. Front Cell Infect Microbiol 2022;12:836409. http://dx.doi.org/10.3389/fcimb.2022.836409CrossRef
[3] Elzein F, Ibrahim A, Alshahrani F, Mahrous M, Murshid E, Aldhehyan T, et al. Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature. J Infect Public Health 2021;14(4):474 − 7. http://dx.doi.org/10.1016/j.jiph.2021.01.002CrossRef
[4] Zhang YP, Luo W, Li Q, Wang XJ, Chen J, Song QF, et al. Risk factors for death among the first 80 543 coronavirus disease 2019 (COVID-19) cases in China: relationships between age, underlying disease, case severity, and region. Clin Infect Dis 2022;74(4):630 − 8. http://dx.doi.org/10.1093/cid/ciab493CrossRef
[5] Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 2021;398(10316):2093 − 100. http://dx.doi.org/10.1016/S0140-6736(21)02249-2CrossRef
[6] Aw D, Woodrow L, Ogliari G, Harwood R. Association of frailty with mortality in older inpatients with COVID-19: a cohort study. Age Ageing 2020;49(6):915 − 22. http://dx.doi.org/10.1093/ageing/afaa184CrossRef
[7] Wang HZ, Miao ZY, Zhang CB, Wei XN, Li XQ. K-SEIR-Sim: a simple customized software for simulating the spread of infectious diseases. Comput Struct Biotechnol J 2021;19:1966 − 75. http://dx.doi.org/10.1016/j.csbj.2021.04.004CrossRef
[8] Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013;381(9868):752 − 62. http://dx.doi.org/10.1016/S0140-6736(12)62167-9CrossRef
[9] O'Caoimh R, Sezgin D, O'Donovan MR, Molloy DW, Clegg A, Rockwood K, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing 2021;50(1):96 − 104. http://dx.doi.org/10.1093/ageing/afaa219CrossRef
[10] Sablerolles RSG, Lafeber M, van Kempen JAL, van de Loo BPA, Boersma E, Rietdijk WJR, et al. Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study. Lancet Healthy Longev 2021;2(3):e163 − 70. http://dx.doi.org/10.1016/S2666-7568(21)00006-4CrossRef
[11] Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD. Management of frailty: opportunities, challenges, and future directions. Lancet 2019;394(10206):1376 − 86. http://dx.doi.org/10.1016/S0140-6736(19)31785-4CrossRef